SharpMed LLC

Delivering the advanced, cost-effective medical devices hospitals need

Print
Claim My Business
Min Investment
$100
Location
SCOTTSDALE, AZ
Offering Date
February 15, 2024
Expected Close Date
September 19, 2024
Target Raise
$50.00K-$1.20M
No. Investors
178
Security Price
$2
Website
sharpmed.com
Number of Employees
0
Cash
$73,268
Revenue
$0
Short Term Debt
$3,846,594
Cost of Goods
$0
Long Term Debt
$2,436,533
Net Income
$-1,041,555

Company Description

At SharpMed, we specialize in designing and launching medical devices tailored to doctors' needs and hospital requirements. We rigorously assess the feasibility of each idea, advancing only those with confirmed viability. This streamlined process takes ‘wickedly cool’ ideas and transforms them into fully

Key Deal Facts

Mission: To become the world's #1 medical device incubator.
Founder: Dr. Chris Salvino: 30-year expert in surgery and bioengineering.
Experience: 100 years developing FDA Class I and II medical devices.
Market: $164 billion medical device market.
Products: Bridging the gap between innovative tech and commercial viability
IP: 6 Issued & 16 pending patents.
Capital Goal & Deployment: This raise will initiate our full roster launch.

Management Team / Advisory Board Bios

Chris Salvino
Founder

Ken Andresen
Chief Financial Officer
Amount Raised : $179,542
Reveal the Score by Voting
_
Additional ratings from other users are needed to determine a viable CrowdScore for this deal.
The "CrowdScore" for this deal is determined by user ratings and other factors using our proprietary algorithm.
The overall viability and scalability of the business concept as well as the ability to drive the concept to profitability over time.
Business Idea
The progress made thus far in demonstrating that the business has viability, a customer base or other business traction.
Business Traction
The experience of the management team in running, scaling and/or exiting a business that required similar skills to execute the business plan.
Management Team
The value of the company compared to similar companies raising money from investors.
Valuation

Research Reports

No reports have been submitted

Become a Reporter

0 Comments